Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism

Background: Visual evoked potential (VEP) measures the time taken for visual stimulus to travel from the eye to the occipital cortex. Hypothyroidism affects the central nervous system (CNS) through its role in gene expression, myelin production, axonal transportation, and neurotransmitters. Delay in...

Full description

Bibliographic Details
Main Authors: Aprajita, Geetanjali Sharma, Sameer Aggarwal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=419;epage=423;aulast=Sharma
_version_ 1819207786698899456
author Aprajita
Geetanjali Sharma
Sameer Aggarwal
author_facet Aprajita
Geetanjali Sharma
Sameer Aggarwal
author_sort Aprajita
collection DOAJ
description Background: Visual evoked potential (VEP) measures the time taken for visual stimulus to travel from the eye to the occipital cortex. Hypothyroidism affects the central nervous system (CNS) through its role in gene expression, myelin production, axonal transportation, and neurotransmitters. Delay in the conduction of impulses results in abnormal VEP. Objective: Correlate the electrophysiological findings of VEP in newly diagnosed treatment-naive hypothyroid patients before and after 3 months of treatment and to find the correlation with serum thyroid-stimulating hormone (TSH) levels. Materials and Methods: VEP was measured using Recorders and Medicare Systems Electromyograph Evoked Potential Mark II machine in 30 patients (serum TSH ≥10 mIU/L) between 18 and 50 years of age who were followed up after 3 months of treatment. Results: The mean age (±standard deviation) of the patients was 31.8 (±8.3) years. There was prolongation of VEP latencies which tends to decrease following hormone replacement therapy. It was found to be most significant for P100 (ms) waveform (P < 0.001). The amplitude (P100-N75 mV) which was decreased in hypothyroid patients showed improvement following achievement of euthyroidism. Significant positive correlation was found between P100, N75 latency and pretreatment serum TSH levels. Conclusion: Hypothyroid patients may have changes in the latencies and the amplitude of VEP which are reversible to a great extent with thyroxine replacement therapy. VEP thus acts as a dependable marker for CNS affection in thyroid diseases to detect subtle early changes and to assess the response to treatment in correlation with the clinical improvement.
first_indexed 2024-12-23T05:29:02Z
format Article
id doaj.art-3a0f50d816d2444bafc4fa0d6abc2b85
institution Directory Open Access Journal
issn 2230-8210
language English
last_indexed 2024-12-23T05:29:02Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Endocrinology and Metabolism
spelling doaj.art-3a0f50d816d2444bafc4fa0d6abc2b852022-12-21T17:58:31ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102017-01-0121341942310.4103/ijem.IJEM_366_16Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidismAprajitaGeetanjali SharmaSameer AggarwalBackground: Visual evoked potential (VEP) measures the time taken for visual stimulus to travel from the eye to the occipital cortex. Hypothyroidism affects the central nervous system (CNS) through its role in gene expression, myelin production, axonal transportation, and neurotransmitters. Delay in the conduction of impulses results in abnormal VEP. Objective: Correlate the electrophysiological findings of VEP in newly diagnosed treatment-naive hypothyroid patients before and after 3 months of treatment and to find the correlation with serum thyroid-stimulating hormone (TSH) levels. Materials and Methods: VEP was measured using Recorders and Medicare Systems Electromyograph Evoked Potential Mark II machine in 30 patients (serum TSH ≥10 mIU/L) between 18 and 50 years of age who were followed up after 3 months of treatment. Results: The mean age (±standard deviation) of the patients was 31.8 (±8.3) years. There was prolongation of VEP latencies which tends to decrease following hormone replacement therapy. It was found to be most significant for P100 (ms) waveform (P < 0.001). The amplitude (P100-N75 mV) which was decreased in hypothyroid patients showed improvement following achievement of euthyroidism. Significant positive correlation was found between P100, N75 latency and pretreatment serum TSH levels. Conclusion: Hypothyroid patients may have changes in the latencies and the amplitude of VEP which are reversible to a great extent with thyroxine replacement therapy. VEP thus acts as a dependable marker for CNS affection in thyroid diseases to detect subtle early changes and to assess the response to treatment in correlation with the clinical improvement.http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=419;epage=423;aulast=SharmaCentral nervous systemvisual evoked potentialsthyroid-stimulating hormone
spellingShingle Aprajita
Geetanjali Sharma
Sameer Aggarwal
Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
Indian Journal of Endocrinology and Metabolism
Central nervous system
visual evoked potentials
thyroid-stimulating hormone
title Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
title_full Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
title_fullStr Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
title_full_unstemmed Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
title_short Visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
title_sort visual evoked potentials in overt hypothyroid patients before and after achievement of euthyroidism
topic Central nervous system
visual evoked potentials
thyroid-stimulating hormone
url http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=419;epage=423;aulast=Sharma
work_keys_str_mv AT aprajita visualevokedpotentialsinoverthypothyroidpatientsbeforeandafterachievementofeuthyroidism
AT geetanjalisharma visualevokedpotentialsinoverthypothyroidpatientsbeforeandafterachievementofeuthyroidism
AT sameeraggarwal visualevokedpotentialsinoverthypothyroidpatientsbeforeandafterachievementofeuthyroidism